|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 15.92 | ACUITE BB- | Downgraded | Issuer not co-operating* | - |
| Total Outstanding | 15.92 | - | - |
| Total Withdrawn | 0.00 | - | - |
| * The issuer did not co-operate; based on best available information. | |||
|
Rating Rationale |
|
Acuité has downgraded the long-term rating to ‘ACUITE BB-’ (read as ACUITE double B minus) from 'ACUITE BB' (read as ACUITE double B) on the Rs.15.92 Cr. bank facilities of PURPLE MICROPORT CARDIOVASCULAR PRIVATE LIMITED (ERSTWHILE PURPLE MEDICAL SOLUTIONS PRIVATE LIMITED) on account of information risk. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
| About the Company |
|
Incorporated in 2007, PURPLE MICROPORT CARDIOVASCULAR PRIVATE LIMITED (ERSTWHILE PURPLE MEDICAL SOLUTIONS PRIVATE LIMITED) is a Mumbai-based company promoted by Mr. Murlidhar Bendale, Mr. Rajesh Srivas, Mr. Brian Lancelot and Mr. Mathew Thomas. The company is the sole distributor for coronary stents of MIV Therapeutics (India) Private Limited (MIV). PMPL holds 100 percent stake in MIV. PMPL and MIV have been merged in FY2020. The group is engaged in manufacturing and distributing coronary stents. |
| Unsupported Rating |
|
Not Applicable |
| Non-cooperation by the issuer/borrower: |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
| Limitation regarding information availability |
| Rating Sensitivity |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Liquidity Position |
|
"No information provided by the issuer / available for Acuite to comment upon." |
| Outlook |
|
Not Applicable |
| Other Factors affecting Rating |
|
None |
| Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
| Operating Income | Rs. Cr. | 101.85 | 75.68 |
| PAT | Rs. Cr. | 3.55 | 2.72 |
| PAT Margin | (%) | 3.48 | 3.59 |
| Total Debt/Tangible Net Worth | Times | 0.74 | 0.66 |
| PBDIT/Interest | Times | 3.57 | 3.38 |
| Status of non-cooperation with previous CRA |
|
Not Applicable |
| Any other information |
|
None |
| Applicable Criteria |
|
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on complexity levels of the rated instrument |
|
||||||||||||||||||||||||||||
| |
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| * The issuer did not co-operate; based on best available information. | |||||||||||||||||||||||||||
Disclosure of list of non-cooperative issuers |
|
• Listed :- https://www.acuite.in/Non-Cooperative_Issuer_Listed.php • Unlisted :- https://www.acuite.in/Non-Cooperative_Issuer_Unlisted.php |
|
Contacts |
About Acuité Ratings & Research |
| © Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |
